Literature DB >> 2579332

Autoradiographic detection of HPRT variants of human lymphocytes resistant to RNA synthesis inhibition.

I M Jones, G Zetterberg, C L Strout, A V Carrano.   

Abstract

The feasibility of using RNA synthesis in freshly isolated, human peripheral blood lymphocytes to detect 6-thioguanine (TG)- and 8-azaguanine (AG)-resistant variants in an autoradiographic assay similar to that of Strauss and Albertini (1979) has been evaluated. In phytohemagglutinin (PHA)-stimulated cultures RNA synthesis and HPRT activity began well in advance of DNA synthesis and increased in parallel during the first 44 h of culture. Introduction of TG or AG with PHA at the beginning of culture completely inhibited DNA synthesis during the first 44 h and reduced RNA synthesis to low levels within 24 h. When TG or AG was added after cells had been in culture for 38 h, DNA synthesis was reduced quickly while RNA synthesis was inhibited more slowly. An autoradiographic assay is described in which freshly isolated lymphocytes are cultured with PHA for 24 h, with or without TG or AG, then labeled with [3H]uridine for 1 h. TG-resistant and AG-resistant variant frequencies for 2 normal individuals and a Lesch-Nyhan individual were determined with this assay. The variant frequencies for the normal individuals ranged from 0.46 to 10.6 X 10(-5) depending upon the selective conditions used. All the Lesch-Nyhan cells were resistant to 0.2 microM-2 mM AG; some were sensitive to 0.2 mM TG and most were sensitive to 2.0 mM TG.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579332     DOI: 10.1016/0027-5107(85)90018-1

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  1 in total

1.  Attempts to use the HPRT-assay as an automated short-term monitor for an acute exposure to mutagens.

Authors:  A Johannisson; B Eriksson; H Amnéus; G Zetterberg
Journal:  Cell Biol Toxicol       Date:  1992 Oct-Dec       Impact factor: 6.691

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.